| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CLINICAL STUDIES |
Department of Paediatrics, Institute of Clinical Sciences, The Sahlgrenska Academy at Göteborg University, S-416 85, Göteborg, Sweden
(Correspondence should be addressed to C Ankarberg-Lindgren;; Email: carina.ankarberg-lindgren{at}vgregion.se)
Objective: To test the clinical usefulness of sensitive commercial immunoassays for determination of low 17β-estradiol concentrations in children.
Methods: The lower limit of detection and clinical usefulness (functional sensitivity) of three commercial estradiol immunoassays were validated by use of 500 sera from prepubertal and pubertal children and 55 pooled sera. The three immunoassays consisted of two modified direct immunoassays; one RIA (Spectria Estradiol RIA) and one time-resolved fluoroimmunoassay (AutoDELFIA Estradiol), both with increased serum volume in relation to antibody concentration and extended incubation time. In the third method, serum was purified and concentrated using diethyl ether extraction prior to measurement by the modified Spectria Estradiol RIA.
Results: The lower limits of detection and clinical usefulness were 9 and 30 pmol/l for the direct RIA, 11 and 50 pmol/l for the AutoDELFIA, and 4 and 6 pmol/l for serum determined by extraction RIA. When measuring the serum pool originating from girls at breast stages 1–2, the direct RIA and AutoDELFIA resulted in significantly higher 17β-estradiol concentrations when compared with the extraction RIA (+58 and +267%, P<0.001). We found a significant difference in 17β-estradiol concentrations between girls at breast stages 1 (median 6 pmol/l) and 2 (median 16 pmol/l), when quantified by the extraction RIA (P<0.0001) but no difference when quantified with the direct RIA (median values 12 and 14 pmol/l respectively).
Conclusion: For determination of low serum 17β-estradiol concentrations in children, an extraction step prior to commercial immunoassay is needed to achieve clinically useful results.
This article has been cited by other articles:
|
|
 |
|
  P. H. A. Ronkainen, V. Kovanen, M. Alen, E. Pollanen, E.-M. Palonen, C. Ankarberg-Lindgren, E. Hamalainen, U. Turpeinen, U. M. Kujala, J. Puolakka, et al. Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs J Appl Physiol, July 1, 2009; 107(1): 25 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ankarberg-Lindgren, E. Norjavaara, M. M. Kushnir, W. L. Roberts, A. L. Rockwood, J. Bergquist, A. M. Bunker, and A. W. Meikle Are Estradiol Results Determined by the Tandem Mass Spectrometry Assay Clinically Useful for Children? Am J Clin Pathol, May 1, 2009; 131(5): 746 - 750. [Full Text] [PDF]
|
|
|
|
|
|
T. Finni, V. Kovanen, P. H. A. Ronkainen, E. Pollanen, G. R. Bashford, J. Kaprio, M. Alen, U. M. Kujala, and S. Sipila Combination of hormone replacement therapy and high physical activity is associated with differences in Achilles tendon size in monozygotic female twin pairs J Appl Physiol, April 1, 2009; 106(4): 1332 - 1337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Allvin, C. Ankarberg-Lindgren, H. Fors, and J. Dahlgren Elevated Serum Levels of Estradiol, Dihydrotestosterone, and Inhibin B in Adult Males Born Small for Gestational Age J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1464 - 1469. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
